Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atai Life Sciences N.V. (NQ: ATAI )

3.410 +0.030 (+0.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 6, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 279,786
Open 3.400
Bid (Size) 3.500 (1)
Ask (Size) 3.630 (5)
Prev. Close 3.380
Today's Range 3.300 - 3.440
52wk Range 2.950 - 17.81
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Psychedelic Stock Gainers And Losers From October 6, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 45.41% at $0.22 
Via Benzinga
Colorado to Vote on Legalizing Psychoactives in November
Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the... 
Via PressReach
Topics Supply Chain
Exposures Supply Chain

Performance

YTD
-55.48%
-55.48%
1 Month
-19.00%
-19.00%
3 Month
-20.14%
-20.14%
6 Month
-29.98%
-29.98%
1 Year
-73.77%
-73.77%

More News

Read More
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
Via PressReach
Topics Cannabis
Exposures Cannabis
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
atai's Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing
Via Benzinga
atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT
From atai Life Sciences
Via Globe NewsWire
Allied, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day
From atai Life Sciences
Via Globe NewsWire
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
September Cannabis Category Performances Ranged From -6.3% To -39.0%
Via Talk Markets
Major Psychedelic Stocks Continued To Decline In September
Via Talk Markets
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Psyched: Autopsy Reveals Death By Ketamine, LSD-Like Drugs Without Hallucinations, DEA & Right To Try Psilocybin
Via Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From September 28, 2022
Via Benzinga
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
Via Benzinga
Atai's New MDMA-Based EMP-01 Compound Moves Forward To The Clinical Stage
Via Benzinga
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD
Via Talk Markets
Psychedelic Stock Gainers And Losers From September 22, 2022
Via Benzinga
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
Via PressReach
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
Via FinancialNewsMedia
Psychedelic Stock Gainers And Losers From September 21, 2022
Via Benzinga
Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From September 19, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.